TNFRSF8 and anaplastic large cell lymphoma: NCT01316146 is a Phase I study of anti-CD30 CAR-T lymphocytes conducted in the USA, which included seven patients with Hodgkin’s lymphoma and two patients with anaplastic large cell lymphoma (ALCL) (103).